Leading neuroscientist wins 2015 CSL Florey Medal
27 November, 2015Professor Perry Bartlett has been presented with the 2015 CSL Florey Medal for his discoveries in the field of neuroscience, including breaking the scientific dogma that the adult brain can't change and regenerate.
The nose knows best
30 October, 2015Researchers have found that the colour of neuronal cells in the nose can be used to diagnose a rare genetic disorder called MELAS syndrome, which can result in stroke and dementia.
So guppies can count
29 October, 2015Researchers have discovered that the humble guppy may be smarter than other fish, with strongly lateralised brains that give them the ability to count.
Automated plate assessment system exceeds expectations
07 October, 2015Shares in LBT Innovations rose almost 20% as the medical technology company received successful results from a clinical trial of its culture plate analysis technology.
Why does cancer cause weight loss?
21 September, 2015An international research team has uncovered the cause of the muscle-wasting disease cachexia in cancer patients. Their study brings hope to the large number of people who suffer from this wasting condition.
Exploring immunology at the Indo-Australian Biotechnology Conference
18 August, 2015The Westmead Millennium Institute for Medical Research will next month host the 11th annual Indo-Australian Biotechnology Conference, providing an opportunity for Australian medical researchers to forge closer links with their Indian counterparts.
Oxford spin-out sold for US$160 million
13 August, 2015Oxford University spin-out company Oxitec, which is commercialising technology to control disease-carrying insects and pests, has been sold to synthetic biology specialist Intrexon Corporation for US$160 million.
Microinjection into plant cells of etiolated seedlings
05 August, 2015 by Tim Kunkel, Albert-Ludwigs-UniversityFor several model systems, microinjection is an established method to introduce DNA into single cells to generate transient and stable transformants. The injection of single cells within plant organs, however, is more difficult.
Novartis flu vaccine business bought by CSL
04 August, 2015CSL has completed its acquisition of the Novartis global influenza vaccine business for a cash consideration of US$275 million. A new subsidiary resulting from the acquisition is set to become the second-largest influenza vaccine business in the US$4 billion global industry.
Rheumatoid arthritis and heart valve disease link
22 July, 2015The overproduction of an inflammatory protein that causes rheumatoid arthritis has also been implicated in the development of heart valve disease.
Creating nanomedicines from antibodies
21 July, 2015A new ARC Linkage grant will assist ongoing development of antibody technology developed by immuno-oncology company Minomic.
The pharmaceutical scientist
14 July, 2015 by Susan WilliamsonProfessor Patrick Sexton, head of the Drug Discovery Biology theme at the Monash Institute of Pharmaceutical Science, reflects on a research career in pharmacology and how working within a large research program that encompasses translational drug discovery, drug delivery and drug development has enriched his team's research.
Stronger stem cells to control inflammation and immune response
07 July, 2015Researchers have discovered a method for culturing stem cells that sees the highly therapeutic cells grow faster and stronger — a breakthrough which is expected to eventually lead to new treatments for transplant patients.
In Vitro Technologies partners with Novus Biologicals in ANZ
02 July, 2015In Vitro Technologies has been announced as the distributor for Novus Biologicals in Australia and New Zealand as of 1 July 2015.
Superbug genome successfully decoded
30 June, 2015Researchers have completed the first large-scale study that uses genomic technology to decode the genes of the bacterium Klebsiella pneumoniae (KP).
